Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.

Poynard, Thierry; Munteanu, Mona; Deckmyn, Olivier; Ngo, Yen; Drane, Fabienne; Castille, Jean Marie; Housset, Chantal; Ratziu, Vlad; Imbert-Bismut, Françoise

Poynard, Thierry; Munteanu, Mona; Deckmyn, Olivier; Ngo, Yen; Drane, Fabienne; Castille, Jean Marie; Housset, Chantal; Ratziu, Vlad; Imbert-Bismut, Françoise.

Affiliation

Poynard T; APHP UPMC Paris Liver Center, Paris, France. tpoynard@teaser.fr

J Hepatol ; 57(3): 541-8, 2012 Sep.

Article in En | MEDLINE | ID: mdl-22612998

Subject(s)

Biomarkers/blood; Disease Progression; Liver Cirrhosis/blood; Liver Cirrhosis/pathology; Adult; Age Factors; Apolipoprotein A-I/blood; Bilirubin/blood; Biopsy; Europe, Eastern/ethnology; Fatty Liver, Alcoholic/complications; Female; Haptoglobins/metabolism; Hepatitis B, Chronic/complications; Hepatitis C, Chronic/complications; Humans; Liver Cirrhosis/etiology; Male; Middle Aged; Middle East/ethnology; alpha-Macroglobulins/metabolism; gamma-Glutamyltransferase/blood

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Biomarkers / Disease Progression / Liver Cirrhosis Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia / Europa Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google